THIS PAGE IS UNDER CONSTRUCTION!
Dr. Robert H. Keller
Dr. R.H. Keller, MD MS FACP, Medical & Research Director of The Biodoron institute of advanced medicine and the CEO and director of research of Vit-Immune, Inc. had a distinguished academic career after medical school at Temple University and training in Internal Medicine, Immunology and Hematology at the University of Rochester and the Mayo Clinic. During a fellowship and subsequent Assistant Professorship at the Mayo Graduate School of Medicine, he introduced a new laboratory technology to identify cells at the Mayo Clinic. Moving to Milwaukee, he became a faculty member in the Departments of Medicine, Pediatrics, Biophysics and Health Science at the Medical College of Wisconsin (Marquette University) and the University of Wisconsin, where he rose to level of Professor. He was also awarded two career development awards (Clinical Investigatorships) and the Superior Performance Award (for research) by the Veteran’s Administration where he served as a Staff Physician and Director of the Marcus Center for Immunology Research. During his academic tenure, he was awarded over 2 million dollars in research grants from both the NIH and VA; served on the scientific review panels for the NIH and VA; published over 100 original articles, invited reviews and book chapters in Immunology, Hematology and Medicine; was awarded two patents and served many consultantships including NASA during the Apollo Program.
In 1994, he founded Biodoron, a state of the art medical clinic for the cutting edge treatment of patients afflicted with chronic illnesses including HIV, Hemophilia, Hepatitis, Chronic Fatigue Syndrome, Autoimmune diseases and after cancer care for rebuilding the immune system. In addition Dr. Keller views aging as an illness and has created a complete program for Anti-Aging. In addition, he founded Vit-Immune, a nutriceutical company to develop unique nutritional products to treat the problems seen in the Biodoron patients for which there are no suitable alternatives. Unlike other nutritional companies, all of Vit-Immune’s products undergo extensive clinical testing before being offered to the patients and the public.
Dr. Robert H. Keller is also Chairman and CEO of Phoenix Biosciences. Dr. Keller has devoted 25 years to researching and studying the immune system, and he is instrumental in the development of the company’s first antiviral agent, PBS119. Dr. Keller has been diligently working with a team of specialists to find a treatment for various forms of immune-based diseases, specifically HIV/AIDS. Phoenix Biosciences is a privately-held biotech company owned by parent company Immune Balance Technologies, LLC (IBT).
Dr. Keller continues his involvement with patient groups by lecturing frequently and serving on the Scientific Advisory Board of the National Hemophilia Federation and COTT and was recently awarded the Physician of the year honor from the PWAC coalition of Broward County and the humanitarian award by the National Hemophilia Federation. He serves as a voluntary Professor at the University of Miami School of Medicine. Dr. Keller hosts a weekly radio show on WAXY 790 AM discussing various aspects of immunology and lectures frequently to CFIDS (CNID), HIV and Hemophilia support groups. He has been named as one of the 2000 Outstanding Scientists of the 21st Century and elected to the Board of Governors of the American Academy of HIV Medicine of the State of Florida. He has also been named as one of the Top Physicians in 2003 by the Consumers’ Research Council of America and will be featured in the: “Guide to America’s Top Physicians” 2003 Edition.
